Neuropathy;Peripheral Clinical Trial
Official title:
A Feasibility Pilot Study on the Effects of Exercise on Chemotherapy-induced Peripheral Neuropathy and Interoceptive Brain Circuitry
This is a feasibility pilot study to initiate a research program to assess the effects of exercise on chemotherapy-induced peripheral neuropathy (numbness, tingling, and pain in the hands and feet).
This is a feasibility pilot study to help obtain external funding for a larger study to assess the effects of exercise on chemotherapy-induced peripheral neuropathy (CIPN), which is a dose-limiting and painful side effect of chemotherapy for which there are no established treatments. The investigators will conduct a two-arm randomized clinical trial in 40 cancer patients receiving chemotherapy where Arm 1 is 12 weeks of exercise during chemotherapy and Arm 2 is 12 weeks of nutrition education (control condition) during chemotherapy. The investigators will acquire data on CIPN via patient reports and clinical assessments as well as general pain and hypothetical mechanistic factors that may help explain how exercise may treat CIPN; these factors include measures of musculoskeletal, cardiovascular, neuropsychological, and immunological function. The primary outcomes are related to the feasibility of identifying, recruiting, and obtaining complete data from research participants. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04699734 -
Peripheral Nerve Block in Patients With Painful Diabetic Polyneuropathy
|
N/A | |
Completed |
NCT04054804 -
Digital Foot Check by Using the D-Foot, a New Software
|
||
Completed |
NCT05161364 -
Kinetic Analysis Due to Foot Dysfunction
|
||
Not yet recruiting |
NCT03899298 -
Safety and Clinical Outcomes With Amniotic and Umbilical Cord Tissue Therapy for Numerous Medical Conditions
|
Phase 1 | |
Completed |
NCT02970006 -
Investigating Mechanisms Underlying Spinal Cord Stimulation Efficacy Using Virtual Reality and Full Body Illusion
|
N/A | |
Recruiting |
NCT05291286 -
BXQ-350 Pharmacokinetic/Pharmacodynamic Study in Cancer Patients
|
Early Phase 1 | |
Recruiting |
NCT04403802 -
Voxx Human Performance Technology Socks for Chemotherapy-Induced Peripheral Neuropathy
|
N/A | |
Enrolling by invitation |
NCT05590117 -
Protective Effect of Pentoxifylline Against Chemotherapy Induced Toxicities in Patients With Colorectal Cancer
|
Early Phase 1 | |
Recruiting |
NCT05624138 -
The Possible Protective Role of Ketotifen Against Oxaliplatin Induced Peripheral Neuropathy
|
Phase 3 | |
Recruiting |
NCT06121232 -
Exploring the Benefit of Neuromodulation in Treating Chemo-induced Peripheral Neuropathy Using Peripheral Neuropathy Markers (Meissner's Corpuscles and Epidermal Nerve Fiber Density) and Sensory Testing (Quantitative Sensory and Gait Testing): A Single Center Feasibility Study
|
N/A | |
Recruiting |
NCT05065554 -
ACALA-R In Predominantly Demyelinating IgM Mediated Neuropathy
|
Phase 2 | |
Recruiting |
NCT05980767 -
Short Duration Electrical Stimulation to Improve Outcomes After Cubital Tunnel Release (SELECT) Trial
|
N/A | |
Completed |
NCT03135535 -
Micro-mobile Foot Compression and Diabetic Foot
|
Phase 2 | |
Recruiting |
NCT03037684 -
Depolarising Electrical Skin Stimulation in Neuropathic and Postoperative Pain
|
||
Recruiting |
NCT04865185 -
Effect of Topical Lidocaine on Warm and Cold Sensation in Healthy Individuals
|
N/A | |
Completed |
NCT05093023 -
ABCB1 SNPs as Predictors of PIPN
|
||
Completed |
NCT05410548 -
Comorbidity Screening and Referral by Prosthetists
|
N/A | |
Not yet recruiting |
NCT06422949 -
Efficacy and Safety of HILOTERM® Device for the Prevention of Peripheral Neuropathy
|
N/A | |
Terminated |
NCT03777956 -
The Effect of Lacosamide in Peripheral Neuropathic Pain
|
Phase 2 | |
Terminated |
NCT04218448 -
Evaluation of the Interest of Hypno-relaxation During Somatosensory Evoked Potentials
|
N/A |